FDA Inspection
Eagle Analytical Services, Inc.Eagle Analytical Services, Inc. – FDA Inspection, Dec 17, 2019
Record Details
This FDA Inspection record concerns Eagle Analytical Services, Inc., with an inspection on December 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 17, 2019
- Product Type
- Drugs
View Company Profile
ID · 555ad202-62a4-4c2f-a9c9-21978c2eff44
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1113094
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.160(b)(4)Establishment of calibration procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eagle Analytical Services, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | VAI | Dallas District Office | Drug Quality Assurance |
| November 30, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eagle Analytical Services, Inc.
- FDA Inspection 1292758 - 2025-11-21
- FDA Inspection 1037197 - 2017-11-30
- FDA Inspection 838134 - 2013-06-17
- FDA Inspection 764056 - 2011-12-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.